NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
62135-506-30 | 62135-506 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20220207 | N/A | ANDA | ANDA211063 | Chartwell RX, LLC | CHLORTHALIDONE | 50 mg/1 | 30 TABLET in 1 BOTTLE (62135-506-30) |
62135-506-90 | 62135-506 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20220207 | N/A | ANDA | ANDA211063 | Chartwell RX, LLC | CHLORTHALIDONE | 50 mg/1 | 90 TABLET in 1 BOTTLE (62135-506-90) |
62135-505-90 | 62135-505 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20220207 | N/A | ANDA | ANDA211063 | Chartwell RX, LLC | CHLORTHALIDONE | 25 mg/1 | 90 TABLET in 1 BOTTLE (62135-505-90) |
62135-505-30 | 62135-505 | HUMAN PRESCRIPTION DRUG | Chlorthalidone | Chlorthalidone | TABLET | ORAL | 20220207 | N/A | ANDA | ANDA211063 | Chartwell RX, LLC | CHLORTHALIDONE | 25 mg/1 | 30 TABLET in 1 BOTTLE (62135-505-30) |